| 1 |
Enhanced Expression of a Biosimilar Monoclonal Antibody with a Novel NS0 Platform
Sampey D, Courville P, Acree D, Hausfeld J, Bentley WE
Biotechnology Progress, 34(2), 455, 2018 |
| 2 |
A Novel Cholesterol/Lipid Delivery System for Murine Myeloma Cell Lines
Chauhan G, Schmelzer AE
Biotechnology Progress, 33(3), 795, 2017 |
| 3 |
Advances in recombinant antibody manufacturing
Kunert R, Reinhart D
Applied Microbiology and Biotechnology, 100(8), 3451, 2016 |
| 4 |
On the Model-Based Optimization of Secreting Mammalian Cell (GS-NS0) Cultures
Kiparissides A, Pistikopoulos EN, Mantalaris A
Biotechnology and Bioengineering, 112(3), 536, 2015 |
| 5 |
Generation of a cholesterol-independent, non-GS NS0 cell line through chemical treatment and application for high titer antibody production
Li JC, Gu W, Edmondson DG, Lu CN, Vijayasankaran N, Figueroa B, Stevenson D, Ryll T, Li F
Biotechnology and Bioengineering, 109(7), 1685, 2012 |
| 6 |
Novel cholesterol feeding strategy enables a high-density cultivation of cholesterol-dependent NS0 cells in linear low-density polyethylene-based disposable bioreactors
Tao YW, Yusuf-Makagiansar H, Shih J, Ryll T, Sinacore M
Biotechnology Letters, 34(8), 1453, 2012 |
| 7 |
Computational approach for understanding and improving GS-NS0 antibody production under hyperosmotic conditions
Ho Y, Kiparissides A, Pistikopoulos EN, Mantalaris A
Journal of Bioscience and Bioengineering, 113(1), 88, 2012 |
| 8 |
Analysis of an Artificially Selected GS-NS0 Variant With Increased Resistance to Apoptosis
Browne SM, Al-Rubeai M
Biotechnology and Bioengineering, 108(4), 880, 2011 |
| 9 |
Enhanced Productivity of NS0 Cells in Fed-Batch Culture with Cholesterol Nanoparticle Supplementation
Wu Y, Ma NN, Wyslouzil BE, Chalmers JJ, McCormick E, Casnocha SA
Biotechnology Progress, 27(3), 796, 2011 |
| 10 |
Detailed Understanding of Enhanced Specific Antibody Productivity in NS0 Myeloma Cells
Khoo SHG, Al-Rubeai M
Biotechnology and Bioengineering, 102(1), 188, 2009 |
